Latent tuberculosis (tb) infection
Drug research and approvals for latent tuberculosis (tb) infection: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 16, 2026, 17 studies of latent tuberculosis (tb) infection are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 17
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
Recruiting Now
Newest start dates first, of 17 recruiting on ClinicalTrials.gov ↗- Screening With Portable X-rays for Rapid Recognition of TBNCT07737275 · Not applicable · Columbia University · starts Aug 25, 2026
- BPaLMZ for TB MeningitisNCT07227779 · Phase 2 · David Boulware · starts Jul 28, 2026
- Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TBNCT06568484 · Phase 2 / Phase 3 · Johns Hopkins University · starts May 8, 2026
- Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)NCT07164742 · Not applicable · Johns Hopkins University · starts Mar 18, 2026
- Shorter and Safer Treatment Regimens for Latent TBNCT06498414 · Phase 2 / Phase 3 · McGill University Health Centre/Research Institute of the McGill University Health Centre · starts Jun 10, 2025
- PRecision biomArker-Guided MAnagement of TuberculosIs Contacts: a Discrete Choice ExperimentNCT07024836 · Not reported · University College, London · starts May 22, 2025
- ESAT6/CFP10 Skin Testing for TB Infection in Rheumatologic PatientsNCT06796647 · Not reported · Chinese University of Hong Kong · starts Mar 19, 2025
- Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB PreventionNCT06281834 · Phase 1 · Brigham and Women's Hospital · starts Nov 15, 2024
- Testing Health Workers At Risk to Advance Our Understanding of TB InfectionNCT06221488 · Not reported · Beth Israel Deaconess Medical Center · starts Jan 15, 2024
- A Novel Therapy With a 1-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis…NCT06022146 · Phase 3 · Huashan Hospital · starts Sep 1, 2023
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA